Tel Aviv, Israel

Tal Recanati

This inventor holds 1 USPTO granted patent. Top assignee: Gentex Corporation. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tal Recanati: Innovator in Vehicle Safety Technology

Introduction

Tal Recanati is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of vehicle safety technology. His innovative work focuses on enhancing the support provided to first responders in the event of vehicle accidents.

Latest Patents

Recanati holds a patent for a "System, device, and method for vehicle post-crash support." This system is designed to provide first responders with critical information regarding the medical status and injuries of vehicle occupants after an accident. The technology includes an in-cabin sensor that captures sensory data through various means, such as image sensors, depth sensors, and micro-vibration sensors. This data encompasses pre-crash, during-crash, and post-crash information, which is analyzed by a dedicated processor.

Career Highlights

Tal Recanati is associated with Gentex Corporation, a company known for its advancements in automotive safety and technology. His work at Gentex Corporation has allowed him to focus on developing innovative solutions that improve emergency response efforts.

Collaborations

Recanati collaborates with Guy Raz, a fellow innovator in the field. Their partnership emphasizes the importance of teamwork in driving technological advancements.

Conclusion

Tal Recanati's contributions to vehicle safety technology exemplify the impact of innovation on emergency response. His patent and work at Gentex Corporation highlight the importance of developing systems that enhance the safety and well-being of individuals involved in vehicle accidents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…